Cancer Research Advances Regarding the CKLF-like MARVEL Transmembrane Domain Containing Family
(ندگان)پدیدآور
Lu, JiaWu, Qian-QianZhou, Ya-BoZhang, Kai-HuaPang, Bing-XinLi, LiangSun, NanWang, Heng-ShuZhang, SongLi, Wen-JianZheng, WeiLiu, Weiنوع مدرک
TextSystematic Review and Meta-analysis
زبان مدرک
Englishچکیده
The CKLF-like MARVEL transmembrane domain-containing family (CMTM) is a novel family of genes first reported at international level by Peking University Human Disease Gene Research Center. The gene products act between chemokines and the transmembrane-4 superfamily. Located in several human chromosomes, the CMTMs CKLF and CMTM1 to CMTM8 may be unregulated in tumors and act as potential tumor suppressor genes with important roles in the immune, male reproductive and hematopoietic systems. In-depth studies in recent years established a close relation between CMTMs and tumorigenesis and metastasis. The CMTM family has a significant clinical value in diagnosis and treatment of diseases linked to tumors and the immune system.
کلید واژگان
CMTM familyGene
chemokine-like factor
Tumor
Diagnosis
treatment
شماره نشریه
6تاریخ نشر
2016-07-011395-04-11
ناشر
West Asia Organization for Cancer Prevention (WAOCP)سازمان پدید آورنده
School of Basic Medical,The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, ChinaSchool of Stomatology,The Fourth Hospital of Hebei Medical University , Shijiazhuang, Hebei, China
School of Public Health,The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
School of Basic Medical,The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
School of Basic Medical,The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
School of Basic Medical,The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Department of Blood Transfusion,The Fourth Hospital of Hebei Medical University,Shijiazhuang, Hebei,China
Department of Pathology, The Second Hospital of Hebei Medical University,Shijiazhuang, Hebei,China
Department of Clinical Laboratory, The Third Affiliated Hospital, Shijiazhuang, Hebei,China
Department of Immunology,Hebei Medical University
Department of Surgical Oncology, Chinese PLA General Hospital, Beijing, China
Department of Immunology,Hebei Medical University
شاپا
1513-73682476-762X




